Synthesis AI
United States
- San Francisco, California
- 28/04/2022
- Series A
- $17,000,000
Pioneering synthetic data technology to build more capable and ethical AI.
- Industry Software Development
- Website https://synthesis.ai/
- LinkedIn https://www.linkedin.com/company/synthesis-ai/
Related People
Yashar BehzadiFounder
United States -
San Francisco Bay Area
Proven executive, experienced technologist, and meticulous product lead with a history of delivering first-in-class products to market.
Specialties:
- Early venture strategy and financing
- Developing novel technologies
- New product introduction and market development across industries
- Building strong teams
- Leading complex and multifaceted product development programs
- Structuring and leading strategic partnerships with large companies
Highlights:
- Launched world's first digital medicines product system (ingestible sensor+pharmaceuticals+wearables+apps)
- Developed first AI-based diagnostic test for broad-spectrum mental illness based on a panel of biomarkers
- 8 years of experience building best-in-class wearables (FDA-approved, CE-marked)
- Pioneered synthetic data technologies for building more capable AI models
- 30+ patents across hardware & software (https://patents.justia.com/inventor/yashar-behzadi)
Lua AI (YC F25) | $5,800,000 | (Apr 17, 2026)
Joyful Health | $17,000,000 | (Apr 17, 2026)
Worki.ai | $2,750,000 | (Apr 17, 2026)
Balerion AI | $6,000,000 | (Apr 17, 2026)
Beeline Medicines | $300,000,000 | (Apr 17, 2026)
Resolv | $1,000,000 | (Apr 17, 2026)
Solidroad | $25,000,000 | (Apr 17, 2026)
Ralio | $2,500,000 | (Apr 16, 2026)
Parasail | $32,000,000 | (Apr 16, 2026)
Modern Relay | $3,000,000 | (Apr 16, 2026)
Gitar | $9,000,000 | (Apr 16, 2026)
Terremoto Biosciences | $108,000,000 | (Apr 16, 2026)